محمد اورکی

Objectives: <span class="fontstyle2">Diabetes is a chronic, multifaceted and threatening disease which has significant psychological complications. The purpose of this study was comparing the efficacy of Acceptance and Commitment Therapy (ACT) and Dialectical Behavioral Therapy Skills Training (DBT-ST) on cognitive emotion regulation in patients with type II diabetes. Method: <span class="fontstyle2">The design of this quasi-experimental research was a pretest-posttest with a control group. The statistical population of the study included all patients with type II diabetes referred to Baghban (Touba) Medical Clinic in Sari in 2019, among whom 45 patients were selected through the convenience sampling method and then randomly assigned into three groups. The first group received ACT, the second group received DBT-ST, and the third group was considered as a control group. Data were collected using a 36-item Cognitive Emotion Regulation Questionnaire (Garnefsky et al., 2001) in three stages of pre-test, post-test, and follow-up, and were analyzed by repeated measurement variance analysis. Results: <span class="fontstyle2">The results showed that ACT and DBT-ST were significantly more effective on cognitive emotion regulation for the experimental groups compared to the control group (effect sizes 0.911 & 0.967, respectively). The effectiveness of DBT-ST compared to ACT was more significant on cognitive emotion regulation scores (effect sizes 0.967) at (P>0.01). Conclusion: <span class="fontstyle2">Based on the results of this study, it can be concluded that ACT improved psychological indexes and mental health of patients with type II diabetes due to acceptance of unfavorable emotions and thoughts, commitment, and DBT-ST for emotion regulation and mindfulness components

Abstract The aim of the present study was investigating the effectiveness of Transcranial Direct Current Stimulation (tDCS) on neurocognitive performance in people with mild neurocognitive impairment. Using meta-analysis and integrating the research results, this study has specified the extent of the effect of Transcranial Direct Current Stimulation on improvement of neurocognitive function in people with mild neurocognitive impairment. Method: For meta-analyses Magiran, SID, and Irandoc databases were used to search Persian articles and Science direct, Scopus, and PubMed databases were used to find foreign articles, using ‘MCI’, ‘transcranial direct current stimulation’, tDCS, and ‘mild cognitive impairment’ key words for foreign articles and their Persian equivalents for Persian articles. Of the 29 studies, 11 that were methodologically acceptable were meta-analyzed. The research tool was a meta-analysis checklist. Results: The results of meta-analysis indicated publication bias in the studies. Due to the heterogeneity of the studies, a random effect model was used. The effect of Hedges for the impact of Transcranial Direct Current Stimulation on neurocognitive functions in people with mild neurocognitive impairment was 0.26, which is a large effect. Conclusion: This result shows clinicians can choose transcranial direct current stimulation (tDCS) as effective intervention for patients who suffer from mild cognitive impairments. More investigations are necessary to find the cognitive benefits of using transcranial direct current stimulation in elderly people and other cognitive impaired persons.

The purpose of this study was to determine the effectiveness of schema therapy on depression and relapse in heroin-dependent men. Method: This research was a semi-experimental study with pretest-posttest design with control group. To perform this research among people who referedto Tehran addiction treatment clinic in October to February 2017, 40 referees were selected and randomly assigned to experimental (20) and control groups (20). In this study, the experimental group received the Yang Scheme Program for 10 sessions of 90 minutes, while the control group was on the waiting list for the treatment. Participants completed a Beck Depression Inventory and a urine test to measure the substance in the pre-test and post-test phases. Analysis of covariance was used to analyze the data. Results: The results showed that in the post-test stage, schema therapy could significantly reduce depression and relapse rate in heroin- dependent men compared to control group. Conclusion: Schema therapy as a leading method in the field of cognitive-behavioral therapy has therapeutic benefits for heroin addicts and is effective in reducing the relaps problem.

Objective: This study aimed at investigating the effectiveness of mindfulness-based cognitive-behavioral therapy on the perceived stress, disease adaptation, quality of life, and cognitive function of patients undergoing chemotherapy. Method: The design of the study was semi-experimental with a pretest-post test and control group. The statistical population of this study was all patients with sarcoma-lymphatic and gastrointestinal cancer undergoing chemotherapy in Firoozgar-Taleghani-Shariati specialized hospitals in Tehran in the second half of 2021. The study sample consisted of 40 patients with cancer who were selected through convenience sampling and then were randomly assigned to experimental and control groups (20 in each group). The therapy was performed by the researcher for eight 90 minutes –sessions, two sessions per week. Research data were collected using Cohen's Perceived Stress Scale, Watson's disease adaptability, Barclay's cognitive functions, and quality of life questionnaires, and were analyzed by multivariate repeated measures variance analysis. Results: The results showed a significant difference in all variables, and demonstrated that mindfulness-based cognitive therapy significantly improved perceived stress, disease adaptation, quality of life, and cognitive functions of participants in the experimental group in the post-test and follow-up. Conclusion: According to the research findings, it can be concluded that mindfulness-based cognitive therapy is effective in improving the psychological indicators of cancer patients.